![Eric S. Furfine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric S. Furfine
Chief Tech/Sci/R&D Officer at
Mosaic Biosciences, Inc.
Profile
Eric S.
Furfine currently works at Ingenia Therapeutics Inc., as Director and Mosaic Biosciences, Inc., as Chief Scientific Officer from 2025.
Dr. Furfine also formerly worked at GlaxoSmithKline LLC, as Director-Biochemical Analytical Pharmacology, Regeneron Pharmaceuticals, Inc., as Vice President-PreClinical Development, ImmuneXcite, Inc., as Chief Executive & Scientific Officer in 2016, Adnexus, as SVP-Research & Preclinical Development, and Sesen Bio, Inc., as Chief Scientific Officer from 2014 to 2016.
Dr. Furfine received his undergraduate degree from Washington University in St. Louis and doctorate degree from Brandeis University.
Eric S. Furfine active positions
| Companies | Position | Start |
|---|---|---|
Ingenia Therapeutics Inc.
 Ingenia Therapeutics Inc. Medical/Nursing ServicesHealth Services Provides health care services | Director/Board Member | - |
Mosaic Biosciences, Inc.
 Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Chief Tech/Sci/R&D Officer | - |
Former positions of Eric S. Furfine
| Companies | Position | End |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/02/2016 |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Chief Executive Officer | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Chief Tech/Sci/R&D Officer | - |
Training of Eric S. Furfine
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mosaic Biosciences, Inc.
Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial research and development services | Commercial Services |
ImmuneXcite, Inc.
ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Ingenia Therapeutics Inc.
Ingenia Therapeutics Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
- Stock Market
- Insiders
- Eric S. Furfine
